H1015
25-羟基胆甾醇
≥98%
别名:
5-胆甾烯-3β,25-二醇
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C27H46O2
化学文摘社编号:
分子量:
402.65
NACRES:
NA.77
PubChem Substance ID:
eCl@ss:
39023139
UNSPSC Code:
41141804
MDL number:
Beilstein/REAXYS Number:
3161259
biological source
synthetic (organic)
Quality Level
assay
≥98%
form
powder
shipped in
ambient
storage temp.
room temp
SMILES string
[H][C@@]12[C@]([C@](CC[C@H](O)C3)(C)C3=CC2)([H])CC[C@@]4(C)[C@@]1([H])CC[C@]4([H])[C@]([H])(C)CCCC(C)(O)C
InChI
1S/C27H46O2/c1-18(7-6-14-25(2,3)29)22-10-11-23-21-9-8-19-17-20(28)12-15-26(19,4)24(21)13-16-27(22,23)5/h8,18,20-24,28-29H,6-7,9-17H2,1-5H3/t18-,20+,21+,22-,23+,24+,26+,27-/m1/s1
InChI key
INBGSXNNRGWLJU-ZHHJOTBYSA-N
Application
25-羟基胆固醇用于治疗小鼠神经母细胞瘤细胞，以激活 ABCA1 信号，并用于与脂肪酸代谢相关的研究。
Biochem/physiol Actions
25-羟基胆固醇是一种侧链氧甾醇，据报道可引发许多胆固醇分子的活化。这引发了它们从细胞膜到内质网（ER）的运动。25-羟基胆固醇影响免疫系统，并在动脉粥样硬化的发病机制中起关键作用。
抑制甾醇调节元件结合蛋白（SREBPs）的裂解。 25-羟基胆固醇通过下调 Bcl-2 表达和激活半胱天冬酶，从而诱导细胞凋亡。
Preparation Note
可以在乙醇中制备 25-羟基胆固醇的储备溶液，并将其溶解在细胞培养基中，使最终浓度为1mg/ml。
Still not finding the right product?
Explore all of our products under 25-羟基胆甾醇
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
商品
Cholesterol synthesis regulation by dietary levels, LDL receptors control lipid-rich LDL particle transport in cells.
肝脏中胆固醇的合成量由饮食中的胆固醇水平来严格调节。LDL受体调节富含脂质的低密度脂蛋白（LDL）颗粒的细胞转运。
25-hydroxycholesterol enhances cytokine release and toll-like receptor 3 response in airway epithelial cells
Koarai A et al
Respiratory Research, 13, doi: 10-doi: 10 (2012)
Ulf Diczfalusy
Biochimie, 95(3), 455-460 (2012-06-27)
The oxysterol 25-hydroxycholesterol is a widely used compound displaying an array of pharmacological actions in in vitro systems and cell based experimental systems. In spite of the frequent use of this compound over the last few decades and a large number
Alastair G Kerr et al.
The Journal of pharmacology and experimental therapeutics, 361(3), 417-428 (2017-04-01)
Hypercholesterolemia remains one of the leading risk factors for the development of cardiovascular disease. Many large double-blind studies have demonstrated that lowering low-density lipoprotein (LDL) cholesterol using a statin can reduce the risk of having a cardiovascular event by approximately
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| H1015-10MG | 04061833663769 |
| H1015-100MG | 04061833076415 |
| H1015-25MG | 04061833663776 |